You searched for ENDV - Page 5 of 5

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Appoints Leader in Field of Pain Management to its Scientific Advisory Board

Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company, this morning announced the appointment of Steven Levin, M.D., to its scientific advisory board. Per the update, Dr. Levin will assist Endonovo to facilitate the SofPulse(R) introduction to healthcare facilities and further develop the Electroceutical(TM) devices pipeline. “Dr. Levin’s vast experience with novel therapies in the anesthesiology … Continue reading “QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Appoints Leader in Field of Pain Management to its Scientific Advisory Board”

Endonovo Therapeutics Inc. (ENDV) Announces Nationwide Strategy as it Promotes Non-Drug Alternative to Opioid Addiction Crisis

Endonovo Therapeutics is developing bioelectronic devices that target patient pain, inflammation and wound recovery The company intends to get its flagship SofPulse device into 600 hospitals within the next 18 months as part of its bid to reduce post-operative drug dependence Drug dependence is regarded as a major contributor to a global opioid epidemic that … Continue reading “Endonovo Therapeutics Inc. (ENDV) Announces Nationwide Strategy as it Promotes Non-Drug Alternative to Opioid Addiction Crisis”

Endonovo Therapeutics Inc. (ENDV) Positioned to Benefit as Wearable Medical Devices Market Projected to Reach $66.8 Billion by 2026

An aging Western population and the prevalence of chronic diseases are expected to contribute to the massive growth of the wearable medical devices market in the years to come Companies like Endonovo Therapeutics are primed to benefit from the growth opportunities due to innovative developments that are currently in the clinical stages Endonovo’s wearable medical … Continue reading “Endonovo Therapeutics Inc. (ENDV) Positioned to Benefit as Wearable Medical Devices Market Projected to Reach $66.8 Billion by 2026”

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Announces Rollout Strategy of SofPulse Post-Operative Opioid Alternative to Hospitals Across U.S.

Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company, this morning announced its strategy for the national rollout of its SofPulse targeted pulsed electromagnetic field (“tPEMF”) therapy device to hospitals throughout the United States. Per the update, Endonovo has recently entered agreements with six master distributors and has hired approximately 40 sales associates, and, within the … Continue reading “QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Announces Rollout Strategy of SofPulse Post-Operative Opioid Alternative to Hospitals Across U.S.”

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Secures Agreement to Distribute SofPulse to Veteran Health Care Facilities

Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company, recently entered an agreement to distribute its SofPulse, an easy-to-place, noninvasive device delivering pulsed electromagnetic frequencies to enhance postsurgical recovery, to Veterans Administration facilities and Department of Defense health care facilities. An article further discussing the company reads, “The long-term agreement recently signed with Veterans Healthcare Supply … Continue reading “QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Secures Agreement to Distribute SofPulse to Veteran Health Care Facilities”

QualityStocksNewsBreaks – Why Endonovo Therapeutics Inc. (ENDV) Is ‘One to Watch’

Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. A recent article discussing the company reads, “Endonovo Therapeutics develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, noninvasive … Continue reading “QualityStocksNewsBreaks – Why Endonovo Therapeutics Inc. (ENDV) Is ‘One to Watch’”

Endonovo Therapeutics Inc. (ENDV) to Distribute Non-Invasive, Wearable Therapeutic Devices to Nation’s Veteran Health Care Facilities

Endonovo’s flagship product, SofPulse, is an easy-to-place, non-invasive device delivering pulsed electromagnetic frequencies to enhance post-surgical recovery The company’s agreement with Veterans Healthcare Supply Solutions Inc. includes distribution of SofPulse to Veterans Administration facilities and Department of Defense health care facilities Treatment with SofPulse allows patients to better manage post-operative pain without the adverse side … Continue reading “Endonovo Therapeutics Inc. (ENDV) to Distribute Non-Invasive, Wearable Therapeutic Devices to Nation’s Veteran Health Care Facilities”

Endonovo Therapeutics Inc. (ENDV) is “One to Watch”

Long-term agreement signed with Veterans Healthcare Supply Solutions Inc. to directly distribute SofPulse devices to Veterans Administration Facilities and Department of Defense Healthcare Facilities Partnership with SunMED Medical Solutions, one of the premier medical equipment distributors and claim experts in the U.S., expands Endonovo’s distribution capabilities and expands ability of providers, facilities and patients to … Continue reading “Endonovo Therapeutics Inc. (ENDV) is “One to Watch””

SeeThruEquity Conference Brings Together Microcap Companies and Investors in New York City

Yesterday, the 5th Annual SeeThruEquity Conference took place at Convene in New York City, connecting more than 30 presenting companies with microcap-focused investors, sponsors and industry professionals. The conference featured 30-minute presentations from each of the presenting companies, as well as opportunities for prospective investors to meet one-on-one with the companies’ management teams. In total, … Continue reading “SeeThruEquity Conference Brings Together Microcap Companies and Investors in New York City”

Site Search

Company Search

Search Results for: ENDV